Literature DB >> 23662896

Quantifying antibody binding on protein microarrays using microarray nonlinear calibration.

Xiaobo Yu1, Garrick Wallstrom, Dewey Mitchell Magee, Ji Qiu, D Eliseo A Mendoza, Jie Wang, Xiaofang Bian, Morgan Graves, Joshua LaBaer.   

Abstract

We present a microarray nonlinear calibration (MiNC) method for quantifying antibody binding to the surface of protein microarrays that significantly increases the linear dynamic range and reduces assay variation compared with traditional approaches. A serological analysis of guinea pig Mycobacterium tuberculosis models showed that a larger number of putative antigen targets were identified with MiNC, which is consistent with the improved assay performance of protein microarrays. MiNC has the potential to be employed in biomedical research using multiplex antibody assays that need quantitation, including the discovery of antibody biomarkers, clinical diagnostics with multi-antibody signatures, and construction of immune mathematical models.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23662896      PMCID: PMC4477631          DOI: 10.2144/000114028

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


  29 in total

1.  Development of an internally controlled antibody microarray.

Authors:  Eric W Olle; Arun Sreekumar; Roscoe L Warner; Shannon D McClintock; Arul M Chinnaiyan; Michael R Bleavins; Timothy D Anderson; Kent J Johnson
Journal:  Mol Cell Proteomics       Date:  2005-07-22       Impact factor: 5.911

Review 2.  Protein biomarker discovery and validation: the long and uncertain path to clinical utility.

Authors:  Nader Rifai; Michael A Gillette; Steven A Carr
Journal:  Nat Biotechnol       Date:  2006-08       Impact factor: 54.908

3.  Antigen microarrays for serodiagnosis of infectious diseases.

Authors:  Letizia Mezzasoma; Tito Bacarese-Hamilton; Manlio Di Cristina; Ruggero Rossi; Francesco Bistoni; Andrea Crisanti
Journal:  Clin Chem       Date:  2002-01       Impact factor: 8.327

Review 4.  Mining the plasma proteome for cancer biomarkers.

Authors:  Samir M Hanash; Sharon J Pitteri; Vitor M Faca
Journal:  Nature       Date:  2008-04-03       Impact factor: 49.962

5.  Clinical proteomics: A need to define the field and to begin to set adequate standards.

Authors:  Harald Mischak; Rolf Apweiler; Rosamonde E Banks; Mark Conaway; Joshua Coon; Anna Dominiczak; Jochen H H Ehrich; Danilo Fliser; Mark Girolami; Henning Hermjakob; Denis Hochstrasser; Joachim Jankowski; Bruce A Julian; Walter Kolch; Ziad A Massy; Christian Neusuess; Jan Novak; Karlheinz Peter; Kasper Rossing; Joost Schanstra; O John Semmes; Dan Theodorescu; Visith Thongboonkerd; Eva M Weissinger; Jennifer E Van Eyk; Tadashi Yamamoto
Journal:  Proteomics Clin Appl       Date:  2007-01-22       Impact factor: 3.494

6.  Dynamic antibody responses to the Mycobacterium tuberculosis proteome.

Authors:  Shajo Kunnath-Velayudhan; Hugh Salamon; Hui-Yun Wang; Amy L Davidow; Douglas M Molina; Vu T Huynh; Daniela M Cirillo; Gerd Michel; Elizabeth A Talbot; Mark D Perkins; Philip L Felgner; Xiaowu Liang; Maria L Gennaro
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-28       Impact factor: 11.205

7.  Protein array profiling of tic patient sera reveals a broad range and enhanced immune response against Group A Streptococcus antigens.

Authors:  Mauro Bombaci; Renata Grifantini; Marirosa Mora; Valerio Reguzzi; Roberto Petracca; Eva Meoni; Sergio Balloni; Chiara Zingaretti; Fabiana Falugi; Andrea G O Manetti; Immaculada Margarit; James M Musser; Francesco Cardona; Graziella Orefici; Guido Grandi; Giuliano Bensi
Journal:  PLoS One       Date:  2009-07-22       Impact factor: 3.240

8.  Self-assembling protein microarrays.

Authors:  Niroshan Ramachandran; Eugenie Hainsworth; Bhupinder Bhullar; Samuel Eisenstein; Benjamin Rosen; Albert Y Lau; Johannes C Walter; Joshua LaBaer
Journal:  Science       Date:  2004-07-02       Impact factor: 47.728

9.  Comparisons of standard curve-fitting methods to quantitate Neisseria meningitidis group A polysaccharide antibody levels by enzyme-linked immunosorbent assay.

Authors:  B D Plikaytis; S H Turner; L L Gheesling; G M Carlone
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

10.  Multiple protein extract microarray for profiling human food-specific immunoglobulins A, M, G and E.

Authors:  N K Renault; S R Gaddipati; F Wulfert; F H Falcone; L Mirotti; P J Tighe; V Wright; M J C Alcocer
Journal:  J Immunol Methods       Date:  2010-10-23       Impact factor: 2.303

View more
  12 in total

1.  Fabricating a UV-Vis and Raman Spectroscopy Immunoassay Platform.

Authors:  Cynthia Hanson; Nathan D Israelsen; Michael Sieverts; Elizabeth Vargis
Journal:  J Vis Exp       Date:  2016-11-10       Impact factor: 1.355

2.  Host-pathogen interaction profiling using self-assembling human protein arrays.

Authors:  Xiaobo Yu; Kimberly B Decker; Kristi Barker; M Ramona Neunuebel; Justin Saul; Morgan Graves; Nathan Westcott; Howard Hang; Joshua LaBaer; Ji Qiu; Matthias P Machner
Journal:  J Proteome Res       Date:  2015-03-18       Impact factor: 4.466

3.  Antibody Profiling by Proteome Microarray with Multiplex Isotype Detection Reveals Overlap between Human and Aotus nancymaae Controlled Malaria Infections.

Authors:  Omid Taghavian; Aarti Jain; Chester J Joyner; Sunny Ketchum; Rie Nakajima; Algis Jasinskas; Li Liang; Rich Fong; Christopher King; Bryan Greenhouse; Maxwell Murphy; Jason Bailey; Mary R Galinski; John W Barnwell; Christopher V Plowe; D Huw Davies; Philip L Felgner
Journal:  Proteomics       Date:  2018-01       Impact factor: 3.984

4.  High-throughput identification of proteins with AMPylation using self-assembled human protein (NAPPA) microarrays.

Authors:  Xiaobo Yu; Joshua LaBaer
Journal:  Nat Protoc       Date:  2015-04-16       Impact factor: 13.491

5.  In-depth proteomics characterization of ∆Np73 effectors identifies key proteins with diagnostic potential implicated in lymphangiogenesis, vasculogenesis and metastasis in colorectal cancer.

Authors:  María Garranzo-Asensio; Javier Rodríguez-Cobos; Coral San Millán; Carmen Poves; María Jesús Fernández-Aceñero; Daniel Pastor-Morate; David Viñal; Ana Montero-Calle; Guillermo Solís-Fernández; María-Ángeles Ceron; Manuel Gámez-Chiachio; Nuria Rodríguez; Ana Guzmán-Aránguez; Rodrigo Barderas; Gemma Domínguez
Journal:  Mol Oncol       Date:  2022-06-07       Impact factor: 7.449

6.  Protein Microarrays for Ocular Diseases.

Authors:  Guillermo Solís-Fernández; Ana Montero-Calle; Miren Alonso-Navarro; Miguel Ángel Fernandez-Torres; Victoria Eugenia Lledó; María Garranzo-Asensio; Rodrigo Barderas; Ana Guzman-Aranguez
Journal:  Methods Mol Biol       Date:  2021

Review 7.  Evaluation of optical detection platforms for multiplexed detection of proteins and the need for point-of-care biosensors for clinical use.

Authors:  Samantha Spindel; Kim E Sapsford
Journal:  Sensors (Basel)       Date:  2014-11-25       Impact factor: 3.576

8.  Identification of prefrontal cortex protein alterations in Alzheimer's disease.

Authors:  Maria Garranzo-Asensio; Pablo San Segundo-Acosta; Javier Martínez-Useros; Ana Montero-Calle; María Jesús Fernández-Aceñero; Anna Häggmark-Månberg; Alberto Pelaez-Garcia; Mayte Villalba; Alberto Rabano; Peter Nilsson; Rodrigo Barderas
Journal:  Oncotarget       Date:  2018-01-24

9.  Serum Protein Profiling Reveals a Landscape of Inflammation and Immune Signaling in Early-stage COVID-19 Infection.

Authors:  Xin Hou; Xiaomei Zhang; Xian Wu; Minya Lu; Dan Wang; Meng Xu; Hongye Wang; Te Liang; Jiayu Dai; Hu Duan; Yingchun Xu; Xiaobo Yu; Yongzhe Li
Journal:  Mol Cell Proteomics       Date:  2020-08-11       Impact factor: 5.911

10.  Comprehensive analysis of immunoglobulin and clinical variables identifies functional linkages and diagnostic indicators associated with Behcet's disease patients receiving immunomodulatory treatment.

Authors:  Linlin Cheng; Yang Li; Ziyan Wu; Liubing Li; Chenxi Liu; Jianhua Liu; Jiayu Dai; Wenjie Zheng; Fengchun Zhang; Liujun Tang; Xiaobo Yu; Yongzhe Li
Journal:  BMC Immunol       Date:  2021-02-22       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.